United Therapeutics Corporation (NASDAQ: UTHR) - Q2 2025 Financial Overview
United Therapeutics continues to advance its mission in the biopharmaceutical sector, with notable developments in revenues, expenses, and ongoing challenges. Below are the key highlights and analysis of their recent inco...